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Abstract
Background: To examine the subjective health status of adults with short stature (ShSt) and
compare with the general population (GP) and one well-known chronic disease, rheumatoid artritis
(RA). In addition, to explore the association between age, gender, height, educational level and
different aspects of health status of adults with short stature.
Methods: A questionnaire was mailed to 72 subjects with short stature registered in the database
of a Norwegian resource centre for rare disorders, response rate 61% (n = 44, age 16–61). Health
status was assessed with SF-36 version 2. Comparison was done with age and gender matched
samples from the general population in Norway (n = 264) and from subjects with RA (n = 88).
Results: The ShSt sample reported statistically significant impaired health status in all SF-36
subscales compared with the GP sample, most in the physical functioning, Mean Difference (MD)
34 (95% Confidence Interval (CI) 25–44). The ShSt reported poorer health status in mental health,
MD 11 (95% CI 4–18) and social functioning, MD 11 (95% CI 2–20) but better in role physical MD
13 (95% CI 1–25) than the RA sample. On the other subscales there were minor difference
between the ShSt and the RA sample. Within the short stature group there was a significant
association between age and all SF-36 physical subcales, height was significantly associated with
physical functioning while level of education was significantly associated with mental health.
Conclusion: People with short stature reported impaired health status in all SF-36 subscales
indicating that they have health problems that influence their daily living. Health status seems to
decline with increasing age, and earlier than in the general population.
Background
People with short stature are a heterogenic group with
very different clinical expressions due to many different
diagnoses with different genetic origins [1]. The literature
uses different definitions of short stature: 3SD, 2.5 percen-
tile or 3th percentile below mean height [2-4]. Several
medical conditions cause short stature, i.e. skeletal dyspla-
sias, metabolic diseases, growth hormone deficit, chronic
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orders. In some cases no cause can be found (idiopathic
short stature). The medical literature describes 200–250
different skeletal dysplasias with distinct medical prob-
lems. Many need highly specialised medical services [3,5-
8].
Short stature caused by skeletal dysplasia is a rare condi-
tion; prevalence at birth is estimated to 1/4000. For
achondroplasia, the most well known skeletal dysplasia,
the prevalence is estimated to 1/15 000–1/40 000 live
births [7].
Persons with short stature encounter several challenges in
daily life. Many have serious medical problems and their
short and often disproportionate stature make life strenu-
ous in an average sized society. The fact that their appear-
ances make them extremely visible in society puts an
additional strain to their lives [9,10].
Most studies conducted with people of short stature
describe different medical problems and their manage-
ment [11-18]. The consequences for daily life have been
addressed in only a few studies and with different meth-
ods. Two Finnish studies [19,20] describe the conse-
quences of short stature for health and quality of life.
American studies including only subjects with achondro-
plasia have described quality of life using different meth-
ods [21,22].
To our knowledge, no studies of people with short stature
have measured several dimensions of health status with
modern methods, or compared health status of people
with short stature with other chronic diseases.
In this study the subjective health status of a group of
adults with short stature (ShSt) was examined and com-
pared with the health status of the general population
(GP) and with that of one other known chronic disease,
Rheumatoid Arthritis (RA). In addition the association
between age, gender, height, educational level and health
status of adults with short stature was explored.
Methods
The study was designed as a cross-sectional postal survey.
TRS is a national resource centre for rare disorders in Nor-
way. Those who seek the services of TRS are included in a
databased register. In October 2004 a questionnaire was
mailed to all persons above 16 years of age (72 persons)
with skeletal dysplasias (osteogenesis imperfecta
excluded) or short stature without known diagnosis. The
questionnaires were returned anonymously.
To be able to compare the SF-36 results from the study
group with other groups, two comparison groups were
established retrospectively: One group from a Norwegian
population study and one group from a register of a well
known chronic disease, Rheumatoid Arthritis.
SF-36 (version 1) data from the general population was
collected by Norwegian Social Science Data Service in
"Level of Living 2002" ("Samordnet levekårsun-
dersøkelse"). A dataset from that study was made availa-
ble to the present study. From this dataset a comparison
group was drawn, individually matched on age and gen-
der (6 persons in the general population for each person
in the short stature sample).
Diakonhjemmet Hospital, Oslo, established in 1994 Oslo
Rheumatoid Arthritis Register (RA-register) [23]. Inclu-
sion criteria in this register are a diagnosis of RA and a res-
idential address in Oslo. Data in the RA-register have been
collected through postal surveys, including the SF 36 (ver-
sion 1) questionnaire. A comparison group was drawn
from data collected in 2004. There were very few persons
below 20 years; this made individual matching on age
impossible. Group matching was done up to 40 years,
while individual matching on age and gender was done
for ages above 40 (2 persons from the RA-register for each
person in the short stature sample).
The survey instruments included demographic data, dis-
ease-specific questions (health problems, medical treat-
ment and the use of welfare services) and the generic
health status instrument MOS SF-36v2. SF-36 is widely
used for measuring subjective health status [24,25]. It
consists of eight subscales (four mental and four physi-
cal): mental health (mh), role functioning emotional (re),
social functioning (sf), vitality (vt) and general health
(gh), bodily pain (bp), physical functioning (pf), role
functioning physical (rp). SF36 exists in two versions; SF-
36 and SF-36v2. The last version corrects deficiencies in
the original version (especially in the two role subscales)
and is calibrated so that the results from the two versions
can be compared [24]. All subscales of the SF-36 have 0–
100 scales, 100 is best health status score. The mean score
and variance vary considerably between the subscales in
normative data.
The data were entered into SPSS 13.0 for Windows for
descriptive and statistical analyses. SF-36 was scored
according to Health survey manual & interpretation guide
[25]. Independent sample t-tests were used to compare
the short stature group with the general population and
the Rheumatoid Arthritis groups. The sample size of both
the study group and the comparison groups (n>30) allow
use of independent sample t-test [26]. When checked for
normality, all variables in the study group were found toPage 2 of 7
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distribution was however somewhat skewed (especially in
the role subscales). Non-parametric tests (Mann-Whitney
test) were therefore also used.
Univariate and multiple linear regressions were used to
assess the influence of age, gender, educational level and
height on the SF-36 scores for the short stature group. Lin-
ear regression was also used to assess the influence of age
and gender on SF-36 scores for the general population. All
models were thoroughly checked for violations from the
linear model assumptions.
National Committee for Research Ethics in Norway
approved the study March 2004
Results
The questionnaire was mailed to 72 persons with short
stature, mean age 35 years, (range 16–71), 67% females.
After one reminder 44 persons (61%) responded. The
mean age of the respondents was 36,4 years (range 16–
61), 32 (73%) were females. The characteristics of the
short stature sample are shown in table 1.
Almost all the respondents had various skeletal dyspla-
sias; achondroplasia being the most frequent diagnosis
(43%), while 18% reported that they did not know any
diagnosis for their short stature. This latter group was ana-
lysed for height (mean height 135,6 cm; range 127–146),
which is not significantly different from the rest of the
study sample.
The short stature sample (ShSt) reported impaired health
status compared to the general population (GP). Statisti-
cal significance was reached in all SF-36 subscales. The dif-
ference between the GP and ShSt was particularly
prominent in the physical subscales: general health, bod-
ily pain, physical functioning and role physical, (27–34
point difference on a 0–100 scale) (table 2). The results
applied to both genders (data not shown).
Comparison between the ShSt and Rheumatoid Arthritis
(RA) samples showed small differences in health status in
most subscales. Persons with ShSt had however higher
scores in the physical role subscale and lower scores in the
mental health, social functioning and vitality subscales
compared to the RA sample. These differences were statis-
tically significant (table 2). All the differences that were
statistically significant when t-tests were used were also
statistically significant when non-parametric tests were
used (results not shown).
Within the ShSt group, the results showed large variation
in all subscales, indicating that some had scores on or
above mean scores for the general population. For
instance, in the physical functioning subscale, 35% scored
75 and higher, indicating good physical functioning, and
22% scored 25 or less, indicating poor physical function-
ing.
People with achondroplasia reported higher scores than
people with the other diagnoses in the subscales bodily
pain and physical functioning. Comparisons of health sta-
Table 1: Characteristisics of the short stature sample (N = 44)
Characteristics n (%) Mean (SD) Range
Age 36.4 (13) 16 – 61
Weight 55,5 (13) 30 – 85




Mobility: use wheelchair 13 (29)
Formal education >12 years 16 (36)
Employment status
Under education 15 (34)
Employed 19 (43)





Spondyloepiphyseal dysplasia 3 (7)
Other skeletal dysplasias* 9 (20)
No diagnosis reported 8 (18)
* chondrodystrophia (1), diastrophic dysplasia (1), dyschondrosteose (2), dysplasia epiphysialis multiplex (2), metaphysial chondrodysplasia (1), 
metatropic dysplasia (1), spondylo meta physical dysplasi Kozlowskys type (1)Page 3 of 7
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of the differences were statistically significant (data not
shown).
Table 3 shows the results of univariate and multivariate
regression analyses for the ShSt group, with age, gender,
height and level of education as independent variables
and the eight subscales in the SF-36 as dependent varia-
bles. There was a significant association between age and
all physical subscales (general health, bodily pain, physi-
cal functioning and role physical) and with the vitality
subscale showing lower scores with higher age. On the
physical functioning subscale there was also a significant
association with height showing lower scores with lower
height. Level of education is the best predictor of health
status in the mental health and role emotional subscales,
with higher scores for those with more than 12 years of
education. In all subscales men had higher scores than
women, but the associations were not statistically signifi-
cant.
Regression analyses for the GP group with age and gender
as independent variables showed few significant associa-
tions with most SF-36 subscales. Higher age was associ-
ated with higher SF-36 scores on mental health and
vitality and lower score on bodily pain (data not shown).
Discussion
This study highlights the fact that living with short stature
affects people across all major dimensions of health as
measured with SF-36 and affects most in the physical sub-
scales. Compared with a sample from the general popula-
tion matched on gender and age, men and women with
short stature report significantly impaired health status.
The low scores in the physical subscales are in accordance
with an American study of people with achondroplasia
that used SF-36 [21]. They found significant lower "Phys-
ical Component Summary" (a weighted score from the
four physical subscales) for people with achondroplasia
than for the general population, but they found no differ-
ences on the "Mental Component Summary". Another
study used a Ferran and Powers Quality of Life Index, and
found lower scores for people with achondroplasia com-
pared with their unaffected first-degree relatives [22]. The
results of the present study are also in accordance with
results from two Finnish studies [19,20]. Those studies
mainly described other short stature diagnoses and used
other health status questionnaires, but the main results
showed the same tendency.
When compared with people with rheumatoid arthritis,
people with short stature report nearly equal health status
in some subscales; better health status in role physical and
lower health status in mental health and social function-
ing subscales. Rheumatoid Arthritis is a well-known
chronic, autoimmune, inflammatory disease that causes
pain and gradual physical disability. Short stature and
skeletal dysplasias are less known and other people may
fail to understand the health challenges and problems
that people with these conditions meet. A comparison
with a well-known group was done to clarify the extent of
these health challenges.
It is well documented that the physical health status
decreases with increasing age in the general population
[27]. Even though the mean age in this study group is
quite low (36,4 years), age is still the most important pre-
dictor of health status in all the physical subscales for peo-
ple with short stature. This was not the case in the age-
matched comparison group from the general population.
This indicates that the decline in health status starts earlier
in people with short stature than in the general popula-
tion. This corresponds to the findings of Mahomed [21]
where the scores in the physical domain declined signifi-
cantly after the fourth decade of life for people with
achondroplasia. Literature describes premature degenera-
tive arthritis as a common problem with increasing age in
some of the skeletal dysplasia diagnoses, i.e. pseudoa-
Table 2: Mean (Standard Deviation) SF-36 scores for the ShSt, the GP and the RA samples. Differences (95% confidence interval) 
between GP and ShSt and between RA and ShSt.
SF-36 subscales Mean(SD) SF-36 scores Differences GP-ShSt Differences RA-ShSt
ShSt n = 44 GP n = 264 RA n = 88 Mean diff (95%CI) p-value Mean diff (95%CI) p-value
Mental health 65(22) 81(14) 76(15) 15 (9 to 22) <0.001 11 (4 to 18) 0.003
Role emotional 74(31) 90(26) 77(37) 16 (6 to 26) 0.002 3 (-9 to 15) 0.663
Social functioning 65(26) 90(17) 76(24) 24 (16 to 33) <0.001 11 (2 to 20) 0.021
Vitality 41(16) 64(17) 47(20) 23 (18 to 28) <0.001 7 (0 to 13) 0.040
General health 51(23) 82(17) 54(24) 32 (24 to 39) <0.001 4 (-5 to 12) 0.403
Bodily pain 47(27) 79(24) 47(19) 31 (23 to 40) <0.001 -1 (-10 to 8) 0.884
Physical functioning 58(31) 93(13) 66(25) 34 (25 to 44) <0.001 8 (-3 to 18) 0.160
Role physical 60(30) 88(27) 47(40) 27 (17 to 37) <0.001 -13 (-25 to -1) 0.038
ShSt: short stature, GP: general population, RA: rheumatoid arthritisPage 4 of 7
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same applies for neurological pathology in other skeletal
dysplasia diagnoses, i.e. achondroplasia, hypocondropla-
sia and spondyloepiphyseal dysplasia [4,5,7]. The pain
and physical disability associated with these pathologies
may contribute to the early decrease of health status in the
short stature sample. Studies on other disabilities also
show that they have increasing physical problems rela-
tively early in life [28,29].
The level of education is the best predictor on the mental
health and role emotional dimensions which is in accord-
ance with findings in a study of health status of people
with ankylosing spondylitis [29].
Gollust et al [22] reported a statistically significant associ-
ation between gender and the total QOL score (and the
subscales "health and functioning", "psychological and
spiritual") with higher scores for men than for women. In
Table 3: Regression coefficients (95% confidence interval) and p-value for age, gender, height and level of education related to SF36 
dimensions for the short stature sample (n = 44).
SF-36 subscales Variables Univariat regression Multiple regression
Coefficient (95%CI) p-value Coefficient (95%CI) p-value
Mental health Age -0.1 (-0.6 to 0.5) 0.817 -0.1 (-0.7 to 0.4) 0.572
Gender -9.5 (-24.3 to 5.2) 0.200 -5.3 (-20.9 to 10.3) 0.497
Height 0.2 (-0.3 to 0.7) 0.451 -0,1 (-0.6 to 0.5) 0.795
Level of education 17.1 (4.2 to 30.0) 0.010 18.1 (3.7 to 32.5) 0.015
Role emotional Age -0.5 (-1.2 to 0.2) 0.153 0.6 (-1.4 to 0.1) 0.097
Gender -12.1 (-32.9 to 8.8) 0.250 -7.1 (-29.3 to 15.1) 0.523
Height 0.2 (-0.5 to 1.0) 0.567 -0.1 (-0.9 to 0.7) 0.727
Level of education 17.3 (-1.5 to 36.2) 0.071 21.0 (0.6 to 41.5) 0.044
Social functioning Age -0.4 (-1.0 to 0.2) 0.219 0.3 (-1.0 to 0.3) 0.344
Gender -14.7 (-32.3 to 2.8) 0.098 -11.0 (-30.6 to 8.7) 0.266
Height 0.3 (-0.3 to 1.0) 0.322 0.2 (-0.5 to 0.9) 0.623
Level of education 1.7 (-15.1 to 18.5) 0.842 0.9 (-17.2 to 19.0) 0.921
Vitality Age -0.5 (-0.8 to -0.1) 0.010 -0.5 (-0.8 to 0.1) 0.020
Gender -6.6 (-17.6 to 4.5) 0.236 -3.8 (-15.3 to 7.7) 0.509
Height 0.1 (-0.2 to 0.5) 0.461 0.0 (-0.4 to 0.4) 0.874
Level of education 1.9 (-8.4 to 12.3) 0.708 3.9 (-6.7 to 14.5) 0.460
General Health Age -0.6 (-1.1 to 0.1) 0.020 -0.6 (-1.2 to -0.0) 0.043
Gender -2.8 (-18.8 to 13.3) 0.729 1.0 (-16.1 to 18.2) 0.904
Height 0.2 (-0.4 to 0.8) 0.460 0.2 (-0.4 to 0.8) 0.588
Level of education 0.6 (-15.5 to 14.3) 0.936 1.8 (-13.9 to 17.6) 0.814
Bodily Pain Age -0.8 (-1.4 to -0.3) 0.005 -0.9 (-1.5 to -0.3) 0.007
Gender -6.1 (-24.4 to 12.2) 0.507 -6.3 (-25.4 to 12.8) 0.507
Height 0.1 (-0.5 to 0.8) 0.653 0.0 (-0.6 to 0.7) 0.917
Level of education -2.8 (-20.0 to 14.2) 0.737 -0.3 (-17.9 to 17.2) 0.971
Physical functioning Age -1.0 (-1.7 to -0.4) 0.004 -0.9 (-1.5 to -0.3) 0.005
Gender -15.4 (-36.0 to 5.2) 0.139 -3.6 (-22.1 to 15.0) 0.699
Height 1.2 (0.5 to 1.8) 0.001 1.1 (0.4 to 1,7) 0.002
Level of education 5.9 (-13.5 to 25.4) 0.541 2.2 (-14.9 to 19.3) 0.795
Role Physical Age -1.1 (-1.7 to -0.4) 0.001 -1.1 (-1.7 to -0.4) 0.002
Gender -13,8 (-34.2 to 6.6) 0.180 -5.4 (-25.2 to 14.3) 0.579
Height 0.7 (0.0 to 1.4) 0.050 0.5 (-0.2 to 1.2) 0.161
Level of education 6.5 (-12.7 to 25.6) 0.499 7.7 (-10.5 to 25.9) 0.396
Coding of categorical variables: male = 1, female = 2; level of education < 12 years = 1, level of education >12 years = 2. Age and height were 
treated as continuous.Page 5 of 7
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gender and all SF-36 subscales was found, but the associ-
ations did not reach statistical significance.
The present findings must be interpreted within the limi-
tations of the study. Only a part of the Norwegian short
stature population is registered at TRS Resource Centre for
Rare Disorders and only 61 % of the eligible persons
answered the questionnaire. As we have no information
of those not registered at TRS, there may be a selection
bias. The data that were used to compare the groups con-
tained data from different studies and also different ver-
sions of SF 36 were used. This makes comparisons of the
role functioning subscales somewhat uncertain. The level
of education has in other studies proved to influence
health status [27,29]. The lack of information on the level
of education in the comparison groups may therefore con-
tribute to a bias in the results. However, aggregated data
from Statistics Norway [30] indicate that the education
level of the ShSt sample does not differ much from the
general population of Norway (30% >12 years of educa-
tion). It is reasonable to assume that the GP sample has a
similar level of education as the population at large, and
it is therefore not likely that the differences in SF-36 scores
can solely be explained by differences in education level.
The number of persons in this survey is small, and in par-
ticular, there are few men. Generalizations from these
results must therefore be made with caution. Finally, the
study sample is very heterogeneous in relation to the dif-
ferent diagnoses that are included. The results showed,
however, no statistically significant differences between
the achondroplasia group and the other diagnoses put
together. This corresponds with the results from Apajasalo
et al [19] who compared three different diagnoses; achon-
droplasia, cartilage-hair- nail hypoplasia and diastrophic
dysplasia and found only small differences in health sta-
tus between the groups.
Conclusion
To our knowledge this is the first study in Norway that
describes health status in people with short stature by a
standardized questionnaire. The results may help to
increase the understanding of the special challenges this
group meets in every day life and thereby be useful to
health personnel in giving services to people with short
stature. The findings indicate that the everyday lives of
persons with short stature are often strenuous. It is impor-
tant that health care professionals and other professionals
understand that living in an average sized world when you
are short, may strain you both physically and mentally.
Their short stature, their visible appearance and their
medical complications may affect their health status. It is,
however, important to bear in mind that the large varia-
tions in the SF-36 scores also indicate that not all people
with short stature have impaired health status, some of
them are in good health, both physically and mentally.
These results may throw light on some aspects of the lives
of people with short stature. More studies are needed to
investigate into the problems with early aging and the
possibility to take actions so that people with short stature
may live less strenuous lives.
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